These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36032600)

  • 1. Intravenous Iron-Carbohydrate Nanoparticles and Their Similars. What Do We Choose?
    Mehedinti AM; Capusa C; Andreiana I; Mircescu G
    Maedica (Bucur); 2022 Jun; 17(2):436-448. PubMed ID: 36032600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?
    Knoeff J; Flühmann B; Mühlebach S
    Eur J Hosp Pharm; 2018 Mar; 25(2):79-84. PubMed ID: 29599970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron sucrose: assessing the similarity between the originator drug and its intended copies.
    Di Francesco T; Philipp E; Borchard G
    Ann N Y Acad Sci; 2017 Nov; 1407(1):63-74. PubMed ID: 29168243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicines in clinical practice: Are colloidal iron sucrose ready-to-use intravenous solutions interchangeable?
    Di Francesco T; Sublet E; Borchard G
    Eur J Pharm Sci; 2019 Apr; 131():69-74. PubMed ID: 30742979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Pai AB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient?
    Di Francesco T; Delafontaine L; Philipp E; Lechat E; Borchard G
    Eur J Pharm Sci; 2020 Feb; 143():105180. PubMed ID: 31841697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice.
    Nikravesh N; Borchard G; Hofmann H; Philipp E; Flühmann B; Wick P
    Nanomedicine; 2020 Jun; 26():102178. PubMed ID: 32145382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
    Stein J; Dignass A; Chow KU
    Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
    Praschberger M; Cornelius C; Schitegg M; Goldenberg H; Scheiber-Mojdehkar B; Sturm B
    Pharm Dev Technol; 2015 Mar; 20(2):176-82. PubMed ID: 24219061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.
    Macdougall IC; Comin-Colet J; Breymann C; Spahn DR; Koutroubakis IE
    Adv Ther; 2020 May; 37(5):1960-2002. PubMed ID: 32297281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
    Rottembourg J; Rostoker G
    Nephrol Ther; 2015 Dec; 11(7):531-42. PubMed ID: 26498106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
    Barot BS; Parejiya PB; Mehta DM; Shelat PK; Shah GB
    Pharm Dev Technol; 2014 Aug; 19(5):513-20. PubMed ID: 23701359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Inflamm Allergy Drug Targets; 2012 Feb; 11(1):66-78. PubMed ID: 22309085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
    Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
    Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars.
    Mühlebach S; Borchard G; Yildiz S
    Nanomedicine (Lond); 2015 Mar; 10(4):659-74. PubMed ID: 25723097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.
    Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA
    ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose.
    Hu S; Liu L; Pollock RF; Pöhlmann J; Wu D; Zhang Y
    J Med Econ; 2022; 25(1):561-570. PubMed ID: 35403540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia.
    Friedrisch JR; Cançado RD
    Rev Bras Hematol Hemoter; 2015; 37(6):400-5. PubMed ID: 26670403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies.
    Borchard G; Flühmann B; Mühlebach S
    Regul Toxicol Pharmacol; 2012 Nov; 64(2):324-8. PubMed ID: 22951348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision.
    Gaspar RS; Silva-Lima B; Magro F; Alcobia A; da Costa FL; Feio J
    Front Med (Lausanne); 2020; 7():590527. PubMed ID: 33330550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.